– Both LNZ100 and LNZ101 Achieved Primary Endpoint of Three-Line or Greater Improvement in Near Visual Acuity, without Losing One Line in Distance Visual Acuity at 1-Hour, 71% and 56% respectively – Both LNZ100 and LNZ101 Maintained Three-Line or Gr
BURLINGTON, Ontario--(BUSINESS WIRE)--$ANRG #ANRG--Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) is pleased to announce the appointments of Paula Myson as Chief Financial Officer (CFO), and Hani Kaissi as Chief Development Officer (CDO),
CHAPEL HILL, N.C. & TORONTO & LONDON & ZUG, Switzerland--(BUSINESS WIRE)--#Europe--AESARA is pleased to announce the appointment of Rohit Borker as VP, Oncology, at AESARA, a digital-forward market access agency that develops innovative and trusted soluti
CAMBRIDGE, Mass.--(BUSINESS WIRE)--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that Jeff Baxter, VBI’s President and CEO, and Da
Provides Update on Impact of Hurricane Ian CHICAGO--(BUSINESS WIRE)--Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), a vertically integrated multistate operator and the No. 1 U.S. wholesaler of branded cannabis products, today ann
Amgen to Join LAB150 to Build Canada’s Next Generation of Life Science Companies TORONTO, Canada & HAMBURG, Germany--(BUSINESS WIRE)--#LifeSciences--Toronto Innovation Acceleration Partners (“TIAP”) and Evotec SE (Frankfurt Stock Exchange: EVT, M
- Series C financing led by NEA - Provides advancement of INV-202 Phase 2 clinical trial in Diabetic Kidney Disease in Q4 MONTREAL--(BUSINESS WIRE)--#AmgenVentures--Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique
**NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.** OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Company”), a life sciences corporation focused on developing an
WALTHAM, Mass.--(BUSINESS WIRE)--La Jolla Pharmaceutical Company, a wholly owned subsidiary of Innoviva, Inc. (Nasdaq: INVA) dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening disea
DUBLIN--(BUSINESS WIRE)--The "Remote Patient Monitoring (RPM) Market by Product (Software, Services, Devices, Cardiology, Neurological, BP Monitors, Neonatal, Weight, Temperature, Neuro), End user (Providers, Hospitals, Clinics, Homecare, Patients, Payers
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.